{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T06:50:53Z","timestamp":1781938253502,"version":"3.54.5"},"reference-count":44,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Int AIDS Soc."],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Progress in reducing and eliminating vertical transmission of HIV in children has stagnated over recent years. Unfortunately, recent decisions in the global donor space are likely to lead to considerably lower funding available for HIV and other disease programmes in high\u2010burden low\u2010 and middle\u2010income settings. Understanding and implementing the most effective strategies to prevent, diagnose, treat and monitor HIV acquisition in children are critical to maximize available resources and provide the best care for children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>A set of tools to support the elimination of vertical transmission and end AIDS in children exists across the cascade of care for pregnant mothers and their children, including those for prevention, diagnosis, treatment, monitoring and service delivery. Each tool comes with its own challenges in implementation and scale\u2010up; however, the effectiveness of many has been well\u2010studied and documented. Ensuring all women living with HIV have consistent and secure access to optimized antiretroviral therapy will prevent the largest number of leaks in the cascade that can lead to vertical transmission events. Implementing effective infant diagnosis strategies, including same\u2010day point\u2010of\u2010care testing and birth testing where feasible, will lead to earlier and faster identification of children living with HIV. Subsequently, rapid linkage to optimized treatment will save and improve the lives of children living with HIV. Finally, implementing accompanying monitoring modalities and country\u2010specific service delivery approaches will improve implementation and the effectiveness of these tools as well as retention and commitment in care programmes by children as they become adolescents and adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Ending AIDS in children is possible. We have the tools to do so. However, now is the time for national, regional and global stakeholders to come together to prioritize children and ensure appropriate funding, implementation and equitable access are in place. Testing infants quickly and accurately for HIV is the first step to ensuring their lifelong health and wellbeing. As national and global public health structures shift, programmes need to act quickly\u2014gains in paediatric HIV cannot be lost but must be accelerated. Doing so will require political will, financing, infrastructure, community\u2010led initiatives, and commitment by and access to all to achieve those goals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jia2.70055","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T14:01:47Z","timestamp":1763128907000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The time is now to use the tools we have to end AIDS in children"],"prefix":"10.1002","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0488-1012","authenticated-orcid":false,"given":"Lara","family":"Vojnov","sequence":"first","affiliation":[{"name":"Global Health Impact Group  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases Harvard T H Chan School of Public Health  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd B.","family":"Mulenga","sequence":"additional","affiliation":[{"name":"Zambian Ministry of Health  Lusaka Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeodata R.","family":"Kikitiinwa","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine Children's Foundation  Kampala Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7216-9302","authenticated-orcid":false,"given":"Alexandra C.","family":"Vrazo","sequence":"additional","affiliation":[{"name":"United States Agency for International Development  Washington DC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Fassinou","family":"Ekou\u00e9vi","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation  Abidjan Cote d'Ivoire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly Pato","family":"Dindi","sequence":"additional","affiliation":[{"name":"National AIDS &amp; STI Control Programme (NASCOP) Ministry of Health  Nairobi Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Appolinaire","family":"Tiam","sequence":"additional","affiliation":[{"name":"Milken Institute School of Public Health Department of Epidemiology and Biostatistics George Washington University  Washington DC USA"},{"name":"Elizabeth Glaser Pediatric AIDS Foundation  Washington DC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Persaud","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Department of Pediatrics Johns Hopkins University of School of Medicine  Baltimore Maryland USA"},{"name":"Department of Molecular Microbiology and Immunology Johns Hopkins Bloomberg School of Public Health  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Mofenson","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation  Washington DC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"UNAIDS.Global AIDS Update 2025: AIDS crisis and the power to transform.2025. (https:\/\/www.unaids.org\/en\/resources\/documents\/2025\/2025\u2010global\u2010aids\u2010update accessed 20 August 2025)."},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26171"},{"key":"e_1_2_8_4_1","unstructured":"UNAIDS.The Global Alliance to End AIDS in Children by 2030. (https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/global\u2010alliance\u2010end\u2010AIDS\u2010in\u2010children_en.pdf accessed 11 April 2025)."},{"key":"e_1_2_8_5_1","unstructured":"Paediatric HIV and TB: Rome Action Plan. (https:\/\/www.paediatrichivactionplan.org accessed 11 April 2025)."},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26423"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26433"},{"key":"e_1_2_8_8_1","unstructured":"amfAR.Impact of stop work orders for PEPFAR programs.2025. (https:\/\/www.amfar.org\/wp\u2010content\/uploads\/2025\/01\/Impact\u2010of\u2010Stop\u2010Work\u2010Orders\u2010for\u2010PEPFAR\u2010Programs\u20102.pdf accessed 11 April 2025)."},{"key":"e_1_2_8_9_1","unstructured":"World Health Organization.Consolidated guidelines on HIV prevention testing treatment service delivery and monitoring: recommendations for a public health approach.2021. (https:\/\/www.who.int\/publications\/i\/item\/9789240031593 accessed 11 April 2025)."},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S84850"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009445"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12397"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000212"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(25)00132-8"},{"key":"e_1_2_8_15_1","unstructured":"World Health Organization.Guidelines on lenacapavir for HIV prevention and testing strategies for long\u2010acting injectable pre\u2010exposure prophylaxis.2025. (https:\/\/www.who.int\/publications\/i\/item\/9789240111608 accessed 20 August 2025)."},{"key":"e_1_2_8_16_1","unstructured":"World Health Organization.Consolidated guidelines on differentiated HIV testing services.2024. (https:\/\/iris.who.int\/bitstream\/handle\/10665\/378162\/9789240096394\u2010eng.pdf?sequence=1 accessed 11 April 2025)."},{"issue":"3","key":"e_1_2_8_17_1","first-page":"171","article-title":"Triple antiretroviral compared with zidovudine and single\u2010dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother\u2010to\u2010child transmission of HIV\u20101 (Kesho Bora study): a randomised controlled trial","volume":"1","author":"Kesho Bora Study Group, de Vincenzi I","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907736"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001612"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(22)00012-1"},{"key":"e_1_2_8_21_1","unstructured":"UNAIDS epidemiological estimates.2023. (https:\/\/aidsinfo.unaids.org accessed 11 April 2025)."},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(24)00240-6"},{"key":"e_1_2_8_23_1","unstructured":"World Health Organization.List of prequalified in vitro diagnostic products.2025. (https:\/\/extranet.who.int\/prequal\/vitro\u2010diagnostics\/prequalified\u2010vitro\u2010diagnostics accessed 11 April 2025)."},{"issue":"11","key":"e_1_2_8_24_1","article-title":"Point\u2010of\u2010care tests detecting HIV nucleic acids for diagnosis of HIV infection in infants and children aged 18 months or less","volume":"2018","author":"Ochodo EA","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01492-1"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00029-2"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.757400"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028510"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyq255"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57050503"},{"key":"e_1_2_8_31_1","unstructured":"World Health Organization.Update on antiretroviral regimens for treating and preventing HIV infection and update on early infant diagnosis of HIV: interim guidance.2018. (https:\/\/iris.who.int\/bitstream\/handle\/10665\/273129\/WHO\u2010CDS\u2010HIV\u201018.19\u2010eng.pdf accessed 20 Aug 2025)."},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.08.002"},{"key":"e_1_2_8_33_1","unstructured":"Clinton Health Access Initiative.2024 HIV Market Report. Issue 15 December2025. (https:\/\/www.clintonhealthaccess.org\/wp\u2010content\/uploads\/2024\/12\/2024\u2010HIV\u2010Market\u2010Report_12.20.24.pdf accessed 11 April 2025)."},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(22)00163-1"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003878"},{"key":"e_1_2_8_36_1","unstructured":"BekkerA.Multidose PK\/safety of dolutegravir dispersible tablets and oral films in neonates: PETITE\u2010DTG study.Conference on Retroviruses and Opportunistic Infections.San Francisco USA.2025. Abstract 122."},{"key":"e_1_2_8_37_1","unstructured":"PanjasawatwongN BekkerA RabieH du ToitS Than\u2010in\u2010atK GroenewaldM et\u00a0al.Alternative dosing of ABC\/3TC dispersible tablets to align with dolutegravir dosing in neonates.Conference on Retroviruses and Opportunistic Infections.San Francisco USA.2025. Abstract 1048."},{"key":"e_1_2_8_38_1","unstructured":"ChandasanaH BrooksKM BuchananAM TanL MujuruH ColbersA et\u00a0al.A single once daily ABC\/DTG\/3TC tablet predicts safe and effective exposures in children 3 to <6kg.Conference on Retroviruses and Opportunistic Infections.San Francisco USA.2025. Abstract 944."},{"key":"e_1_2_8_39_1","unstructured":"UNAIDS. Fact sheet.2024. (https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf accessed 11 April 2025)."},{"key":"e_1_2_8_40_1","unstructured":"World Health Organization.HIV molecular diagnostics toolkit to improve access to viral load testing and infant diagnosis.2019. (https:\/\/www.who.int\/publications\/i\/item\/9789241516211 accessed 11 April 2025)."},{"key":"e_1_2_8_41_1","unstructured":"World Health Organization.Updated recommendations on HIV prevention infant diagnosis antiretroviral initiation and monitoring.2021. (https:\/\/www.who.int\/publications\/i\/item\/9789240022232 accessed 11 April 2025)."},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004076"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy113"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30526-1"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003887"}],"container-title":["Journal of the International AIDS Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.70055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:53:37Z","timestamp":1764140017000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jia2.70055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1002\/jia2.70055"],"URL":"https:\/\/doi.org\/10.1002\/jia2.70055","archive":["Portico"],"relation":{},"ISSN":["1758-2652","1758-2652"],"issn-type":[{"value":"1758-2652","type":"print"},{"value":"1758-2652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"2025-05-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70055"}}